Free Trial
OTCMKTS:PKPH

Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis

Peak Pharmaceuticals logo
$0.50 -0.35 (-41.18%)
As of 10/30/2026

About Peak Pharmaceuticals Stock (OTCMKTS:PKPH)

Advanced

Key Stats

Today's Range
$0.46
▼
$0.50
50-Day Range
$0.84
▼
$1.00
52-Week Range
$0.52
▼
$9.12
Volume
2,055 shs
Average Volume
9,053 shs
Market Capitalization
$196 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Receive PKPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PKPH Stock News Headlines

Peak Pharmaceuticals Inc (PKPH)
Akari Therapeutics Merges with Peak Bio for Growth
The 401k Email 70 Million Investors Might Delete
An email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will delete it without a second look. Larry Benedict says that would be a mistake. He calls this the decade's biggest opportunity and is naming the one ticker to watch before it arrives. Watch his free breakdown now.tc pixel
Daytime and early peak commissioning
See More Headlines

PKPH Stock Analysis - Frequently Asked Questions

Peak Pharmaceuticals' stock was trading at $1.6427 at the beginning of the year. Since then, PKPH stock has decreased by 69.6% and is now trading at $0.50.

Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/01/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:PKPH
CIK
1452804
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$160 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-159.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.15

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
392,000
Free Float
320,000
Market Cap
$196 thousand
Optionable
Not Optionable
Beta
0.54
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:PKPH) was last updated on 10/30/2026 by MarketBeat.com Staff.
From Our Partners